IP Library Granted Patent US 10,398,640
Granted Patent B2
US 10,398,640 · App. 14/935,686 · Granted Sep 3, 2019

Methods for treating scars and aging skin

Inventor: Alan David Widgerow (Irvine, CA)
A61K8/97A61K8/602A61K8/891A61K9/0014A61K9/06A61K31/7048A61K36/00A61K36/23A61K36/63A61K36/88A61K36/896A61Q19/00A61Q19/08A61K2800/49A61K2800/524A61K2800/596A61K2800/70A61K2800/87
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,398,640
App. No.
14/935,686
Granted
Sep 3, 2019
Kind
B2
Abstract

Beneficial topical compositions for treating scar or aging skin are provided. In one embodiment, the compositions include Bulbine frutescens, Centella asiatica and a phenol derived from olives, such as oleuropein. The composition may be used in the treatment of scars formed during surgery. The composition may also be used cosmeceutically in the treatment of aged skin, and may include phosphatidylserine, vitamins, and other beneficial anti-aging ingredients.

Claims (14)

1. A method for treating scarred skin, said method comprising:

applying at least one extract of Bulbine frutescens to the scarred skin, in an amount from about 1.25 mg to 25 mg;

applying at least one extract of Centella asiatica to the scarred skin, in an amount from about 0.5 mg to 25 mg.

applying oleuropein to the scarred skin, in an amount from about 0.5 mg to 2.5 mg; and

applying dimethicone, poloxamer, and propylene glycol to the scarred skin;

wherein said Bulbine frutescens, Centella asiatica , oleuropein, dimethicone, poloxamer, and propylene glycol are applied daily and simultaneously.

2. The method of claim 1 , further comprising applying at least one of the following:

water;

at least one preservative;

at least one gelling agent;

at least one solvent;

at least one pH balancing agent; and

at least one surfactant.

3. The method of claim 1 , further comprising providing a dual-chambered device that separates the Bulbine, Centella , oleuropein and silicone from one or more additional ingredients.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2023
From: WIDGEROW, ALAN DAVID
To: ALLERGAN, INC.
Reel/Frame 065132/0349 →
Priority Claims (2)
ZA 2008/08004 · Sep 18, 2008 · national
ZA 2009/04000 · Jun 8, 2009 · national
Continuity (5)
Continuation 13294957 · Nov 11, 2011
Continuation 13294116 · Nov 10, 2011
Continuation In Part 12554364 · Sep 4, 2009
Provisional Application 61094170 · Sep 4, 2008
Related Publication 20160058816A1 · Mar 3, 2016
Cited By (1)
US 12,678,390